IAPP and Hyperglycemia: In fact, genetically modified rodent models expressing human IAPP demonstrate aggressive diabetic-like phenotype, such as insulin impairments and hyperglycemia, with IAPP deposits and β-cell loss (Clark et al., 1995; Janson et al., 1996).